葵花药业集团股份有限公司关于投资设立葵花药业集团（哈尔滨）医药有限公司的进展公告

Investment Overview - The company has decided to establish a wholly-owned subsidiary, Harbin Pharmaceutical Co., Ltd., with an investment of RMB 10 million [2] - The decision was made during the fifth board meeting held on July 25, 2025 [2] Progress of Investment - The subsidiary has completed the registration process and obtained a business license issued by the Harbin New Area Management Committee [2] - The registered address of the subsidiary is located at No. 18, Donghu Road, Yingshan Road, Harbin Economic Development Zone, Heilongjiang Province [2] - The business scope includes drug wholesale, retail, import and export, internet information services related to drugs, food sales, and various other services [2] Company Details - The subsidiary is registered with a capital of RMB 10 million [3] - It is classified as a limited liability company [3] - The establishment date of the subsidiary is August 5, 2025, with Liu Guangtao as the legal representative [3]